China heads into Lunar New Year on shutdown as virus spreads to Europe
By Judy Hua and Cate Cadell BEIJING (Reuters) – A new coronavirus that has killed 26 people...
Read More
Updated
Bayer faces fourth U.S. Roundup cancer trial in Monsanto’s hometown
By Tina Bellon (Reuters) – Bayer AG is set to face a fourth U.S. jury trial over allegations...
Read More
Coronavirus worries have surgical masks flying off shelves in New York’s Chinatown
By Gabriella Borter NEW YORK (Reuters) – Teresa Zhan, a pharmacist in Manhattan’s...
Read More
Bayer Roundup cancer trial postponed to continue settlement talks
By Tina Bellon (Reuters) – Bayer AG said on Friday it has reached an agreement with...
Read More
Novartis, GBT sickle cell drugs too expensive, draft U.S. report says
By John Miller ZURICH (Reuters) – Sickle cell disease drugs made by Novartis and Global...
Read More
Parties unite over Taiwan’s exclusion from WHO anti-virus planning
TAIPEI (Reuters) – Taiwan’s exclusion from World Health Organization meetings on the...
Read More
Yemen’s frontline port struggles to fight deadly fever
HODEIDAH, Yemen (Reuters) – In the grounds of a bombed-out building in the port that has...
Read More
Insys founder Kapoor sentenced to 66 months in prison for opioid scheme
By Tim McLaughlin BOSTON (Reuters) – John Kapoor, the founder of Insys Therapeutics Inc, on...
Read MoreEpizyme prices rare tissue cancer treatment at $15,500 a month
By Manas Mishra and Dania Nadeem (Reuters) – Epizyme Inc on Thursday priced its treatment for a ultra rare, slow growing type of cancer that affects soft tissue at $15,500 per month after getting an approval from the U.S....
Read More
Canada girds for new coronavirus, 17 years after deadly SARS epidemic
By Rod Nickel and Denise Paglinawan WINNIPEG, Manitoba/TORONTO (Reuters) – The arrival of a...
Read More
Blues health insurers put up $55 million to take on generic drug makers
By Caroline Humer NEW YORK (Reuters) – A group of Blue Cross Blue Shield insurers is...
Read MoreWork to start on three possible China virus vaccines: epidemic response group
By Kate Kelland, Health and Science Correspondent LONDON, Jan 23 (Reuters) – Three separate research teams backed by a global coalition set up to fight epidemic diseases are to start work on developing potential vaccines...
Read More
WHO says will decide on Thursday if China virus is a global health emergency
GENEVA (Reuters) – The World Health Organization (WHO) said it will decide on Thursday...
Read More
16 people monitored for contact with U.S. coronavirus victim
(Reuters) – At least 16 people had close contact with a Washington state man diagnosed as...
Read More
Roche’s SMA drug trial win bolsters $2 billion sales prospects
ZURICH (Reuters) – Roche’s spinal muscular atrophy (SMA) drug risdiplam hit another...
Read MoreEndometriosis drug reduces bleeding in women with fibroids
By Gene Emery (Reuters Health) – The AbbVie drug elagolix, already used to treat the pain of endometriosis, can significantly reduce the chances of heavy menstrual bleeding caused by uterine fibroids, according to the...
Read More
French Senate approves bill allowing IVF for single women, lesbians
By Elizabeth Pineau PARIS (Reuters) – France’s Senate voted on Wednesday in favor of a...
Read More
China’s Wuhan shuts down transport as global alarm mounts over virus spread
By Cate Cadell and David Stanway BEIJING/SHANGHAI (Reuters) – Deaths from China’s new...
Read More
Cathay to let crew wear masks on all flights due to new coronavirus
By Jamie Freed SYDNEY (Reuters) – Hong Kong’s Cathay Pacific Airways Ltd...
Read MoreSarepta shares fall 4% after FDA documents show safety concerns about drug
By Carl O’Donnell (Reuters) – Shares of Sarepta Therapeutics Inc were down around 4% Wednesday after the U.S. Food and Drug Administration revealed documents detailing concerns it had about the safety and efficacy of...
Read More